Insider buying last 90 days
No open-market insider purchases were filed for ARX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
This week's attention centers on a proposed sale of Accelerant to private equity firm Thoma Bravo at $20.25 per share, a deal now facing scrutiny from law firm Julie & Holleman LLP, which is investigating the transaction over conflicts involving the controlling shareholder. Separately, attention also turns to the company's upcoming third quarter 2026 results, with analysts examining metrics beyond the standard revenue and EPS estimates for the quarter ended September 2026.
ARX closed at $19.88, essentially flat on the day, with the close sitting above both the 50-day average of $19.78 and the 200-day average of $15.14. The stock trades near its 52-week high of $19.90, well above its 52-week low of $9.18, and carries a six-month return of 48.8% and a one-year return of 65%. The GekkoIndex reads 51.4, placing it in the Neutral zone, down 3.1 over the past five sessions. Price sits just 0.5% below Gekko Fair Value of $19.97, a narrow gap by recent standards.
Earnings are due on 12 November 2026, just 2 days away, placing the report inside a typical 20-trading-day holding window; the company has beaten EPS estimates in 6 of its last 6 quarters, with an average absolute reaction of 11.4% historically. The consensus among 5 analysts includes 1 buy, 3 hold, and 1 sell ratings, with a consensus target of $20.25 and consensus upside of 1.9%. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, though two billionaire holders are noted in current positioning.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Accelerant scores 1 supportive, 2 mixed and 0 headwinds across the 3 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $19.85 is above the 50-day ($19.80) and 200-day ($15.26) averages, and the 50-day is above the 200-day.
See the chart53.2, Neutral
Reading 53.2 is in the Neutral zone.
See the GekkoIndex0.7% below
Price is within 5% of Gekko Fair Value (0.7% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyNo data
No confirmed report date on the calendar.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Accelerant closed at $19.85 on Nov 13, 2026, +57.5% over the past year, inside a 52-week range of $9.18 to $19.91.
Use the left and right arrow keys to read daily values.
Put ARX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Accelerant runs a risk exchange that links specialty insurance underwriters with partners who supply risk capital, using a shared platform built on technology and data. Through this exchange, chosen underwriting members can access capital and services designed to support the placement and management of specialty insurance business. The company is known for this exchange model rather than for selling insurance directly to the public, and its focus falls on small-to-medium sized commercial clients across the United States, Europe, Canada, Australia and the United Kingdom.
The business is organised into three parts. Exchange Services covers the platform itself, including the technology, data handling and agency work that supports members and capital partners, with capital partners paying a fixed, volume-based fee for having their business sourced and monitored. MGA Operations reflects fees earned by members for originating and underwriting policies, net of the costs of providing those services. Underwriting covers the writing of insurance and reinsurance policies through the company's own consolidated insurers, giving current and prospective capital partners a route into the portfolio.
Accelerant was founded in 2018 and is based in Grand Cayman, Cayman Islands. Its shares are listed on the NYSE under the ticker ARX.
Accelerant’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.2, in the Neutral zone, up 4.1 points over five sessions.
Up 4.1 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | −3.2% | −9.6% | ||
| Accumulation | 104 | +1.8% | +5.6% | ||
| Neutral (current zone) | 166 | −0.1% | −1.2% | ||
| Distribution | 21 | −3.9% | −4.7% | ||
| Selling | 2 | Too few readings yet | |||
Average ARX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Accelerant trades 0.7% below Gekko Fair Value of $19.98, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Accelerant shares are worth, recalculated every trading day.
$19.98
Gekko Fair Value, Nov 14, 2026
0.7% below fair value · About fair value
At the end of Aug 2026 the price was 3.4% below the estimate.
No open-market insider purchases were filed for Accelerant, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ARX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ARX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Accelerant has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold ARX.
Accelerant beat the EPS estimate in 6 of its last 6 reports, moving 11.4% on average across the report.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 17, 2026 | $0.32 est $0.16 | — | −2.7% |
| May 13, 2026 | $0.17 est $0.16 | $273.3M est $244.6M | +8.3% |
| Mar 18, 2026 | $0.23 est $0.22 | $248.4M est $252.4M | +4.7% |
| Nov 12, 2025 | $0.39 est $0.21 | $267.4M est $253.5M | +9.7% |
| Aug 28, 2025 | $0.14 est $0.13 | $204.2M est $239.0M | −31.5% |
| May 28, 2025 | $2.65 est $0.00 | $170.7M | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Accelerant is $20.25, +2.0% from the last close, from 3 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 3 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 23 | Raymond James | $12 | −39.5% |
| Aug 20 | TD Cowen | $30 | +51.1% |
| Aug 17 | Raymond James | — | — |
| Aug 15 | William Blair | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Accelerant’s market cap is $4.31B and revenue of $1.07B over the last twelve months.
6 headlines about Accelerant from the past week, newest first, each linking to the publisher.
Accelerant’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BRK.ABerkshire Hathaway | Distribution | 10.8% above |
| BRK.BBerkshire Hathaway | Distribution | 9.8% above |
| CBChubb | Neutral | 4.8% above |
| TRVTravelers Companies | Neutral | 6.3% above |
| HIGHartford Insurance | Neutral | 0.1% below |
| MKLMarkel | Neutral | 4.8% above |
A peer links to its own page where one exists.
Accelerant’s market cap is $4.31B at the Nov 13, 2026 close of $19.85, with 118.5M shares outstanding.
The consensus analyst 12-month price target for Accelerant is $20.25, +2.0% from the last close. Of the 3 firms that rated the stock in the last 90 days, 1 rate it a buy, 1 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Accelerant is about fair value: the Nov 13, 2026 close of $19.85 is 0.7% below Gekko Fair Value of $19.98. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Accelerant’s 52-week high is $19.91 and its 52-week low is $9.18; it closed at $19.85 on Nov 13, 2026, +57.5% over the past year. Over the last five years the shares peaked at $31.18 on Jul 25, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 3 items with data read as supportive (trend), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.